This inventor holds 1 USPTO granted patent. Top assignee: Research Development Foundation. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Edward F McClay: Innovator in Cancer Treatment
Introduction
Edward F McClay is a notable inventor based in Charleston, SC (US). He has made significant contributions to the field of cancer treatment through his innovative research and development efforts. His work primarily focuses on the treatment of non-melanoma cancers, showcasing his commitment to improving patient outcomes.
Latest Patents
Edward F McClay holds a patent for a groundbreaking invention titled "Combination platinum chemotherapeutic/antiestrogen therapy for human." This patent presents a composition of matter designed for the treatment of non-melanoma cancers. The composition comprises a platinum anti-neoplastic compound and tamoxifen, which together exert a synergistic anti-tumor effect on non-melanoma cancer. Additionally, the patent outlines various methods for treating these cancers and strategies for preventing or overcoming resistance to platinum-containing anti-neoplastic compounds. He has 1 patent to his name.
Career Highlights
Edward F McClay is associated with the Research Development Foundation, where he continues to advance his research in cancer therapies. His work is characterized by a strong focus on innovative solutions that address critical health challenges.
Collaborations
Throughout his career, Edward has collaborated with esteemed colleagues, including Stephen B Howell and Gerrit Los. These partnerships have further enriched his research and contributed to the development of effective cancer treatment strategies.
Conclusion
Edward F McClay stands out as a dedicated inventor in the realm of cancer treatment, with a focus on innovative therapies that aim to improve the lives of patients suffering from non-melanoma cancers. His contributions to the field are invaluable and reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile